The Discounted Cash Flow (DCF) valuation of BioRestorative Therapies Inc (BRTX) is (49.55) USD. With the latest stock price at 1.59 USD, the upside of BioRestorative Therapies Inc based on DCF is -3216.6%.
Based on the latest price of 1.59 USD and our DCF valuation, BioRestorative Therapies Inc (BRTX) is a sell. selling BRTX stocks now will result in a potential gain of 3216.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.9% - 6.3% | 5.6% |
| Long-term Growth Rate | 3.0% - 4.6% | 3.8% |
| Fair Price | (342.05) - (27.32) | (49.55) |
| Upside | -21612.7% - -1817.9% | -3216.6% |